DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 4594--------------------------------------------------
       (Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus...
   DIR By: agate
       Date: October 23, 2024, 1:11 am
       ---------------------------------------------------------
       From Nature (October 22, 2024)--"Evaluating efficacy and safety
       of ocrelizumab (Xacrel) compared to the originator (Ocrevus) in
       relapsing multiple sclerosis: A phase 3, randomized,
       equivalency, clinical trial":
  HTML https://www.nature.com/articles/s41598-024-75745-y
       *****************************************************
       Page 1 of 1